HCMT
ALNY icon

Highland Capital Management (Texas)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Highland Capital Management (Texas)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-20,000
Closed -$1.56M – 221
2014
Q3 		$1.56M Buy
+20,000
New +$1.29M 0.06% 152
2013
Q3 		– Sell
-26,592
Closed -$824K – 181
2013
Q2 		$824K Buy
+26,592
New +$708K 0.06% 97

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Highland Capital Management (Texas)'s ALNY Position: Q4 2014 in Review

Highland Capital Management (Texas) sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2014, closing a stake of 20,000 shares — an estimated $1.56M sold.

Highland Capital Management (Texas) first reported a position in ALNY in Q2 2013 and held it in 2 quarters. The position peaked at $1.56M in Q3 2014. 216 funds tracked by Wall St. Rank hold ALNY as of Q4 2014.

  • Highland Capital Management (Texas) reported no remaining Alnylam Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 20,000 Alnylam Pharmaceuticals shares in Q4 2014, an estimated $1.56M.
  • Highland Capital Management (Texas) first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Alnylam Pharmaceuticals position peaked at $1.56M in Q3 2014.
  • 216 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2014.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2014, filed 13 Feb 2015.